New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

Londonwide Enterprise update (17 Aug 2016)

Practice managers conference and events Speakers have been confirmed for the Practice Manager Conference to be held at Woburn House on Thursday 22 September 2016. ‘Leadership through Change: making the...
Read more »

Patient engagement survey (17 Aug 2016)

We are asking for practices to share their experience of successfully developing their patient engagement work, including top tips, by completing our patient engagement surveys. These will help shape the...
Read more »

London Improvement Grant Fund 2017-18 (17 Aug 2016)

The London Improvement Grant Fund application process is now open. Practices need to submit their applications by 17:00 on Friday 30 September 2016 by emailing them to: England.LondonIGfund@nhs.net.  Practices should...
Read more »

NHS England Update on Estates and Technology Transformation Fund (ETTF) (17 Aug 2016)

Unfortunately, information regarding submission dates for reimbursement claims  for NHS England’s Estates and Technology Transformation Fund (ETTF) has caused some confusion. Please note that the submission date change is not related...
Read more »

New GPSoE Resources - Posters (16 Aug 2016)

We have produced two posters to help practices explain to patients and staff why we are in a state of emergency. One is for your waiting room and outlines the...
Read more »

Capita list cleanse plan (16 Aug 2016)

At the end of July it was reported that part of the new Primary Care Support Services contract between NHS England and Capita would include a list cleanse programme, designed...
Read more »

New requirements for hospitals re work with general practice (16 Aug 2016)

Londonwide LMCs’ CEO Dr Michelle Drage has written to Trust and Foundation Trust CEOs across London asking how they plan to implement the new requirements outlined in the 2016/17 NHS...
Read more »

General Practice Resilience Programme funding (16 Aug 2016)

£2.65m of resilience funding is available to London practices this financial year, as the Capital’s share of a £16m national pot, promised as part of the GP Forward View. This...
Read more »

TPP QRISK2 error – responsibility for practices (16 Aug 2016)

NHS England is concerned that only around half of practices affected by the TPP QRISK2 error have accessed the lists of affected patients provided to them.  Dr Andrew Green,...
Read more »
Next Page »
« Previous Page